CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 25 enrolled
Drug / intervention
Paracetamol +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01332578
NCT01332578Phase 4Completed
CompareCT.gov

A Comparison of Solid and Soluble Forms of Cold and Influenza Remedies

GlaxoSmithKline·interventional·Posted Apr 11, 2011·Updated Jun 1, 2015

In Brief

A Phase 4 clinical trial evaluating Paracetamol, Phenylephrine, and 1 other intervention for Influenza and Common Cold. Completed, enrolled 25 participants across 1 site.

Detailed Summary

The study is designed to investigate whether paracetamol from a hot remedy reaches the plasma faster than standard paracetamol tablets. The study will also assess the gastrointestinal transit of two oral cold and influenza ('flu') formulations using gamma scintigraphy. It is postulated that paracetamol in solution, such as from cold and 'flu' hot remedies, provides a greater early exposure compared to standard paracetamol tablets. In addition, the pharmacokinetic (PK) profile of paracetamol in the two formulations will be investigated.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza, Common Cold
CountriesUnited Kingdom
Collaborators--

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 11, 2011
Enrollment StartMay 1, 2011
Primary CompletionJun 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 15.2 years ago

Interventions

Paracetamoldrug

Present in both test and active comparator

Phenylephrinedrug

Test product

Ascorbic Aciddrug

Test product